Abhilasha Nair

5PUBLICATIONS
62CO-AUTHORS
Molecular targetsCancer geneticsFlight dynamicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 02, 2023
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.

Elizabeth S Duke, Diana Bradford, Michelle Marcovitz

|Apr 03, 2023
FDA Oncology Center of Excellence Crowdsourcing Initiative: Outreach to the Scientific Community to Identify Research Questions for Pooled Analyses of Oncology Clinical Trial Data.

Julie A Schneider, Julia Eckstein, Kirsten B Goldberg

|Feb 01, 2023
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response.

Jaleh Fallah, Chana Weinstock, Gautam U Mehta

|Sep 16, 2022
FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.

Elizabeth S Duke, Liza Stapleford, Nicole Drezner

|Aug 04, 2022
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer.

Mirat Shah, Christy L Osgood, Anup K Amatya

Pageof 1

Frequent Collaborators

5 joint publications

Richard Pazdur

3 joint publications

Anup K Amatya

2 joint publications

Youwei Bi

2 joint publications

Jeanne Fourie Zirkelbach